The historical rank and industry rank for Shilpa Medicare's OCF Margin % or its related term are showing as below:
BOM:530549'
s OCF Margin % Range Over the Past 10 Years
Min: 5.13 Med: 11.08 Max: 22.24
Current: 22.25
During the past 13 years, the highest OCF Margin % of Shilpa Medicare was 22.24%. The lowest was 5.13%. And the median was 11.08%.
BOM:530549's OCF Margin % is ranked better than 81.75% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs BOM:530549: 22.25
Shilpa Medicare OCF Margin % Related Terms
Shilpa Medicare OCF Margin % Historical Data
* Premium members only.
The historical data trend for Shilpa Medicare's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shilpa Medicare OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Shilpa Medicare's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shilpa Medicare (BOM:530549) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shilpa Medicare and its competitors. Over the past decade, Shilpa Medicare's OCF Margin % has ranged from 5.13 to 22.24. According to the industry distribution chart, Shilpa Medicare ranks #175 out of 959 companies in the Drug Manufacturers industry, placing it in the top 18.2%.
Is Shilpa Medicare's OCF Margin % too high?
Shilpa Medicare's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 5.13 to a high of 22.24. Based on the distribution chart, Shilpa Medicare ranks #175 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shilpa Medicare has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shilpa Medicare's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shilpa Medicare ranks #175 out of 959 companies for OCF Margin %. This places Shilpa Medicare in the top 18% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Historically, Shilpa Medicare's own OCF Margin % has ranged from 5.13 to 22.24 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shilpa Medicare and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shilpa Medicare's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shilpa Medicare stock overvalued right now?
Based on GuruFocus' analysis, Shilpa Medicare (BOM:530549) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹391.01, compared to a current price of ₹579.40 — trading 48.2% above its estimated fair value. The current OCF Margin % is 0.00%. Shilpa Medicare's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Shilpa Medicare (BOM:530549), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shilpa Medicare (BOM:530549) Overvalued in 2026?
Based on GuruFocus' analysis, Shilpa Medicare stock appears to be overvalued.
The current stock price of ₹579.40 is trading 48.2% above its estimated GF Value™ of ₹391.01.
GuruFocus considers Shilpa Medicare to be Significantly Overvalued.
Key valuation signals for BOM:530549:
OCF Margin %: 0.00%
GF Value™: ₹391.01 vs. price of ₹579.40 (48.2% above fair value)
No single metric tells the full story. See the BOM:530549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.
71GF Score
Get the complete analysis for BOM:530549
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530549 has been successfully added to your 
